Summary
President Trump announced plans to impose 100% tariffs on generic drugs starting August 2028, aiming to relocate production to the US and align drug prices with other nations. The report also notes potential additional tariffs on other countries and products, and frames the move as a permanent policy tool that could endure beyond Trump's term and help the administration's affordability messaging ahead of midterm elections.
- President Trump announced 100% tariffs on generic drugs from August 2028.
- The policy seeks to force generic drug manufacturing to the US and make US prices comparable to other high-cost nations.
- Generic drugs account for over 90% of prescriptions in the US.
- Tariffs on branded drugs were already addressed via an executive order in April.
- Further tariff announcements on other countries and product lists are expected this week.
- The tariff tool can remain in place even without Congressional control and beyond Trump's presidency.
- The administration views the most favored nations drug pricing policy as an affordability win ahead of the November elections.